Rani Therapeutics Holdings CEO Talat Imran's 2022 pay falls 63% to $4.3M
Rani Therapeutics Holdings reports 2022 executive compensation
By ExecPay News
Published: April 11, 2023
Rani Therapeutics Holdings reported fiscal year 2022 executive compensation information on April 11, 2023.
In 2022, three executives at Rani Therapeutics Holdings received on average a compensation package of $2.9M, a 47% decrease compared to previous year.
Average pay of disclosed executives at Rani Therapeutics Holdings
Talat Imran, Chief Executive Officer, received $4.3M in total, which decreased by 63% compared to 2021. 54% of Imran's compensation, or $2.3M, was in option awards. Imran also received $312K in non-equity incentive plan, $515K in salary, as well as $1.1M in stock awards.
Mir Hashim, Chief Scientific Officer, received a compensation package of $2.3M, which decreased by 54% compared to previous year. 48% of the compensation package, or $1.1M, was in option awards.
Svai Sanford, Chief Financial Officer, earned $2M in 2022, a 58% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 11, 2023.